BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23143147)

  • 1. Resection strategies for neuroendocrine pancreatic neoplasms.
    Watzka FM; Laumen C; Fottner C; Weber MM; Schad A; Lang H; Musholt TJ
    Langenbecks Arch Surg; 2013 Mar; 398(3):431-40. PubMed ID: 23143147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of laparoscopic surgery for pancreatic neuroendocrine tumors.
    Haugvik SP; Marangos IP; Røsok BI; Pomianowska E; Gladhaug IP; Mathisen O; Edwin B
    World J Surg; 2013 Mar; 37(3):582-90. PubMed ID: 23263686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?
    Chivukula SV; Tierney JF; Hertl M; Poirier J; Keutgen XM
    Surgery; 2020 Jan; 167(1):180-186. PubMed ID: 31537303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections.
    Hackert T; Hinz U; Fritz S; Strobel O; Schneider L; Hartwig W; Büchler MW; Werner J
    Langenbecks Arch Surg; 2011 Dec; 396(8):1197-203. PubMed ID: 21553230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
    Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
    Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate?
    Pitt SC; Pitt HA; Baker MS; Christians K; Touzios JG; Kiely JM; Weber SM; Wilson SD; Howard TJ; Talamonti MS; Rikkers LF
    J Gastrointest Surg; 2009 Sep; 13(9):1692-8. PubMed ID: 19548038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic Risk in Pancreatic Neuroendocrine Tumors: An 18-Year Experience From Bogotá, Colombia-A Case Series.
    Guzmán Ruiz YF; González Devia D; Vera Torres A; López Panqueva RDP; Ardila Duarte G
    Pancreas; 2020 Sep; 49(8):e68-e70. PubMed ID: 32833947
    [No Abstract]   [Full Text] [Related]  

  • 8. Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience.
    Ito H; Abramson M; Ito K; Swanson E; Cho N; Ruan DT; Swanson RS; Whang EE
    J Gastrointest Surg; 2010 May; 14(5):891-8. PubMed ID: 20224984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases.
    Zerbi A; Capitanio V; Boninsegna L; Pasquali C; Rindi G; Delle Fave G; Del Chiaro M; Casadei R; Falconi M;
    Langenbecks Arch Surg; 2011 Mar; 396(3):313-21. PubMed ID: 20857140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One hundred thirty resections for pancreatic neuroendocrine tumor: evaluating the impact of minimally invasive and parenchyma-sparing techniques.
    DiNorcia J; Lee MK; Reavey PL; Genkinger JM; Lee JA; Schrope BA; Chabot JA; Allendorf JD
    J Gastrointest Surg; 2010 Oct; 14(10):1536-46. PubMed ID: 20824378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on surgical treatment of pancreatic neuroendocrine neoplasms.
    D'Haese JG; Tosolini C; Ceyhan GO; Kong B; Esposito I; Michalski CW; Kleeff J
    World J Gastroenterol; 2014 Oct; 20(38):13893-8. PubMed ID: 25320524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis on laparoscopic pancreatic resections for neuroendocrine neoplasms (PNENs).
    Tamburrino D; Partelli S; Renzi C; Crippa S; Muffatti F; Perali C; Parisi A; Randolph J; Fusai GK; Cirocchi R; Falconi M
    Expert Rev Gastroenterol Hepatol; 2017 Jan; 11(1):65-73. PubMed ID: 27781493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
    Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
    Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.
    Cienfuegos JA; Salguero J; Núñez-Córdoba JM; Ruiz-Canela M; Benito A; Ocaña S; Zozaya G; Martí-Cruchaga P; Pardo F; Hernández-Lizoáin JL; Rotellar F
    Surg Endosc; 2017 Oct; 31(10):3847-3857. PubMed ID: 28127714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of functional and nonfunctional neuroendocrine tumors in the pancreas and peripancreatic region.
    Wang SE; Su CH; Kuo YJ; Shyr YM; Li AF; Chen TH; Wu CW; Lee CH
    Pancreas; 2011 Mar; 40(2):253-9. PubMed ID: 20966805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1.
    Lopez CL; Waldmann J; Fendrich V; Langer P; Kann PH; Bartsch DK
    Langenbecks Arch Surg; 2011 Dec; 396(8):1187-96. PubMed ID: 21805182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
    Kazanjian KK; Reber HA; Hines OJ
    Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study.
    Zerbi A; Capitanio V; Boninsegna L; Delle Fave G; Pasquali C; Rindi G; Campana D; Falconi M;
    HPB (Oxford); 2013 Dec; 15(12):935-43. PubMed ID: 23472667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and Long-Term Outcomes of Laparoscopic Organ-Sparing Resection for Pancreatic Neuroendocrine Neoplasms.
    Zhang RC; Ma J; Mou YP; Zhou YC; Jin WW; Lu C
    World J Surg; 2020 Nov; 44(11):3795-3800. PubMed ID: 32700111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic Contact Between T and N Classifications in Resected Well-Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms.
    Xu JZ; Wang WQ; Zhang SR; Xu HX; Wu CT; Qi ZH; Gao HL; Ni QX; Liu L; Yu XJ
    Ann Surg Oncol; 2018 Mar; 25(3):647-654. PubMed ID: 29235006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.